Ypsomed

Ypsomed's vulnerability footprint centers on its diabetes-management platforms MyLife and MyLife Cloud, which deliver insulin-pump control and therapy data to patients and clinicians. The observed weakness classes—insufficiently protected credentials, hard-coded credentials, predictable initialization vectors in cipher operations, and insufficient randomness in cryptographic constructs—reflect the authentication and encryption demands of connected medical devices handling sensitive health data. Current severity, exploitation status, and exposure counts are shown alongside this summary.